Reappraisal of β-blocker therapy in the acute and chronic post–myocardial infarction period
- 1 May 2004
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (9) , 21-29
- https://doi.org/10.1016/j.amjcard.2004.01.021
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- β-Blockers in the Post–Myocardial Infarction PatientCirculation, 2002
- AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 UpdateCirculation, 2001
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- The Lipid Treatment Assessment Project (L-TAP)Archives of internal medicine (1960), 2000
- National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients After Acute Myocardial InfarctionPublished by American Medical Association (AMA) ,1998
- Changes in Absolute and Relative Importance in the Prognostic Value of Left Ventricular Systolic Function and Congestive Heart Failure After Acute Myocardial InfarctionThe American Journal of Cardiology, 1998
- Chronic Heart Failure in the United StatesCirculation, 1998
- Improvement in cardiac myocyte function by biological effects of medical therapy: A new concept in the treatment of heart failureEuropean Heart Journal, 1995
- Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockadeJournal of the American College of Cardiology, 1995
- Is There a Role for Beta‐blockers in Hypertensive Diabetic Patients?Diabetic Medicine, 1994